Efficacy of Empagliflozin Versus Placebo in Patients With Recent Acute Myocardial Infarction: A Systematic Review

dc.contributor.authorCarlos Mejia
dc.contributor.authorJose R Flores Valdés
dc.contributor.authorDominique Alvarado Corletto
dc.contributor.authorMilton Abraham Trujillo Asturias
dc.contributor.authorA.C. Zea Mendoza
dc.contributor.authorPaulina Razo
dc.contributor.authorJaqueline L Castillo
dc.contributor.authorDavid Antonio Morelos-Flores
dc.contributor.authorEdwin A Garcia-Vasquez
dc.contributor.authorLuis F López Hernández
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:06:19Z
dc.date.available2026-03-22T21:06:19Z
dc.date.issued2025
dc.identifier.doi10.7759/cureus.87354
dc.identifier.urihttps://doi.org/10.7759/cureus.87354
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85956
dc.language.isoen
dc.publisherCureus, Inc.
dc.relation.ispartofCureus
dc.sourceUniversidad Autónoma de Guadalajara
dc.subjectMedicine
dc.subjectEmpagliflozin
dc.subjectMyocardial infarction
dc.subjectPlacebo
dc.subjectInternal medicine
dc.subjectCardiology
dc.subjectIntensive care medicine
dc.titleEfficacy of Empagliflozin Versus Placebo in Patients With Recent Acute Myocardial Infarction: A Systematic Review
dc.typereview

Files